lenvatinib/everolimus in refractory mrcc
Published 5 years ago • 61 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
2:40
efficacy and safety of lenvatinib/everolimus in mrcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
0:58
dr. funahashi on enhanced activity with lenvatinib/everolimus combo in rcc
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:15
q-twist of lenvatinib everolimus in advanced rcc
-
6:42
the role of lenvatinib in advanced rcc